{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:06:39Z","timestamp":1779188799758,"version":"3.51.4"},"reference-count":42,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Lower Extremity Wounds"],"abstract":"<jats:p>\n                    Growing evidence has supported the potential method of umbilical cord mesenchymal stem cell (UCMSC) therapy for diabetic foot and lower extremity peripheral artery disease (PAD), but their results are not consistent. Thus, the authors conducted the first meta-analysis concerning the safety and ef\ufb01cacy of UCMSC treatment in diabetic foot patients. 8 English and Chinese databases were searched to identify randomized controlled trials regarding UCMSC therapy in diabetic foot patients. Two independent investigators carried out literature inclusion, data extraction, and quality assessment. Meta-analysis was performed using ReviewManager 5.4.1., 6 RCT studies involving 380 patients were included. Primary endpoints included ulcer healing, transcutaneous oxygen pressure (TcPO\n                    <jats:sub>2<\/jats:sub>\n                    ), ankle-brachial index (ABI), and intermittent claudication. Compared with conventional treatment, patients who accepted UCMSC therapy had a better ulcer healing rate (Odds Ratio (OR)\u2009=\u20092.88 [1.20\u20136.91]), TcPO\n                    <jats:sub>2<\/jats:sub>\n                    (standardized mean difference (SMD)\u2009=\u20091.39, [0.01\u20132.77]), and ABI improvement (SMD=1.22 [0.30\u20132.13]). Moreover, they also experienced significantly better improvements in pain amelioration, skin temperature, and ulcer area reduction. Whereas, intermittent claudication cannot be ameliorated by UCMSC therapy (SMD=0.83 [-0.45\u20132.10]). Additionally, neovascularization, examined by angiography, was significantly promoted after UCMSC administration. Moreover, two studies recorded adverse events during follow-up, which were considered to be transient, minor, and regional. The present meta-analysis validated that UCMSC treatment enhances diabetic foot ulcer healing and circulation recovery, and has a promising safety profile, though limited by incomplete reporting. Larger-sample multicenter randomized controlled trials and longer-term follow-up are urgently needed to further explore the safety and ef\ufb01cacy of UCMSC treatment in diabetic foot patients. The meta-analysis was prospectively registered on PROSPERO.\n                  <\/jats:p>","DOI":"10.1177\/15347346261426552","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T18:08:30Z","timestamp":1773252510000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Diabetic Foot Ulcers and Peripheral Artery Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.1177","author":[{"given":"Haorui","family":"Zhang","sequence":"first","affiliation":[{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanrui","family":"Gu","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Zhang","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0445-2810","authenticated-orcid":false,"given":"Chenxi","family":"Ouyang","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000558"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","unstructured":"Correction to: Heart disease and stroke statistics-2018 update: A report from the American Heart Association. Circulation. 2018;137(12):e493.","DOI":"10.1161\/CIR.0000000000000573"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-Society consensus for the management of peripheral arterial disease (TASC II)","volume":"45","author":"Norgren L","year":"2007","unstructured":"Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(Suppl S):S5-67.","journal-title":"J Vasc Surg"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-141-6-200409210-00007"},{"issue":"6","key":"e_1_3_2_6_2","first-page":"362","article-title":"Lower extremity peripheral artery disease: Diagnosis and treatment","volume":"99","author":"Firnhaber JM","year":"2019","unstructured":"Firnhaber JM, Powell CS. Lower extremity peripheral artery disease: Diagnosis and treatment. Am Fam Physician. 2019;99(6):362\u2013369.","journal-title":"Am Fam Physician"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2015.10.022"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.10578"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.3923\/pjbs.2012.789.794"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-197404000-00001"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4612167"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms140611692"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-021-02222-y"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20081807"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2021.0218"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.7237"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2015.06.011"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-103684"},{"issue":"23","key":"e_1_3_2_19_2","first-page":"3670","article-title":"Umbilical cord mesenchymal stem cell transplantation for treatment of diabetic lower limb vascular disease","volume":"18","author":"Li X","year":"2014","unstructured":"Li X, Zhu L, Song G, et al. Umbilical cord mesenchymal stem cell transplantation for treatment of diabetic lower limb vascular disease. Chin J Tissue Eng Res. 2014;18(23):3670\u20133675.","journal-title":"Chin J Tissue Eng Res"},{"issue":"2","key":"e_1_3_2_20_2","first-page":"191","article-title":"Clinical evaluation of human umbilical cord blood mesenchymal stem cell transplantation in treatment of diabetic foot","volume":"42","author":"Guo J","year":"2013","unstructured":"Guo J, Li X, Li H. Clinical evaluation of human umbilical cord blood mesenchymal stem cell transplantation in treatment of diabetic foot. Shaanxi Medical Journal. 2013;42(2):191\u2013192.","journal-title":"Shaanxi Medical Journal"},{"issue":"10","key":"e_1_3_2_21_2","first-page":"173","article-title":"Stem cell transplantation for the treatment of diabetic foot","volume":"17","author":"Wang G","year":"2013","unstructured":"Wang G, Zhu L, Ma L, et al. Stem cell transplantation for the treatment of diabetic foot. Chin J Tissue Eng Res. 2013;17(10):173.","journal-title":"Chin J Tissue Eng Res"},{"issue":"1","key":"e_1_3_2_22_2","first-page":"175","article-title":"Umbilical cord blood stem cell transplantation for the treatment of diabetic foot in 23 cases","volume":"16","author":"Zhu L","year":"2012","unstructured":"Zhu L, Wang G, Ma L, et al. Umbilical cord blood stem cell transplantation for the treatment of diabetic foot in 23 cases. Chin J Tissue Eng Res. 2012;16(1):175.","journal-title":"Chin J Tissue Eng Res"},{"issue":"24","key":"e_1_3_2_23_2","first-page":"4593","article-title":"Umbilical cord blood stem cell transplantation for the treatment of diabetic foot in 11 cases","volume":"13","author":"Yu C","year":"2009","unstructured":"Yu C, Cui Z, Liu C. Umbilical cord blood stem cell transplantation for the treatment of diabetic foot in 11 cases. Chin J Tissue Eng Res. 2009;13(24):4593\u20134596.","journal-title":"Chin J Tissue Eng Res"},{"issue":"11","key":"e_1_3_2_24_2","first-page":"1664","article-title":"Effect and potential mechanism of local injection of umbilical cord mesenchymal stem cells in treatment of diabetic foot","volume":"32","author":"Sui P","year":"2020","unstructured":"Sui P, Lijuan S, Ying L, et al. Effect and potential mechanism of local injection of umbilical cord mesenchymal stem cells in treatment of diabetic foot. Medical Journal of West China. 2020;32(11):1664\u20131668.","journal-title":"Medical Journal of West China"},{"key":"e_1_3_2_25_2","article-title":"Prospective, randomized, and controlled study of a human umbilical cord mesenchymal stem cell injection for treating diabetic foot ulcers","volume":"193","author":"Zhang J","unstructured":"Zhang J, Zhao B, Wei W, et al. Prospective, randomized, and controlled study of a human umbilical cord mesenchymal stem cell injection for treating diabetic foot ulcers. J Vis Exp. 2023;193: e65045.","journal-title":"J Vis Exp"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/iwj.13001"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-023-03427-z"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2018.07.023"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e318276fbcb"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199202063260605"},{"issue":"11","key":"e_1_3_2_31_2","first-page":"188","article-title":"Intermittent claudication and asymptomatic peripheral arterial disease","volume":"117","author":"R\u00fcmenapf G","year":"2020","unstructured":"R\u00fcmenapf G, Morbach S, Schmidt A, et al. Intermittent claudication and asymptomatic peripheral arterial disease. Dtsch Arztebl Int. 2020;117(11):188\u2013193.","journal-title":"Dtsch Arztebl Int"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000039526.42991.93"},{"issue":"12","key":"e_1_3_2_33_2","article-title":"Exercise for intermittent claudication","author":"Lane R","unstructured":"Lane R, Harwood A, Watson L, et al. Exercise for intermittent claudication. Cochrane Database Syst Rev. 2017;(12):CD000990.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03530120067043"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.12.043"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2019.01.031"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.2174\/13816128113199990326"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-91291-3"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-011-1083-z"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/86490"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.744868"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgz169"},{"issue":"4","key":"e_1_3_2_43_2","first-page":"2126","article-title":"Adipose-derived mesenchymal stem cells exhibit tumor tropism and promote tumorsphere formation of breast cancer cells","volume":"41","author":"Chen Y","year":"2019","unstructured":"Chen Y, He Y, Wang X, et al. Adipose-derived mesenchymal stem cells exhibit tumor tropism and promote tumorsphere formation of breast cancer cells. Oncol Rep. 2019;41(4):2126\u20132136.","journal-title":"Oncol Rep"}],"container-title":["The International Journal of Lower Extremity Wounds"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15347346261426552","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/15347346261426552","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15347346261426552","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T10:12:23Z","timestamp":1779185543000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/15347346261426552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":42,"alternative-id":["10.1177\/15347346261426552"],"URL":"https:\/\/doi.org\/10.1177\/15347346261426552","relation":{},"ISSN":["1534-7346","1552-6941"],"issn-type":[{"value":"1534-7346","type":"print"},{"value":"1552-6941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"article-number":"15347346261426552"}}